x
Visit our new Mobile Website next time you access NetDania with your mobile device

ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES

28.07
01-19:59:59 GMT
+0.37
+1.34%
ISIN:N/A

Figures - ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES

Open
27.71
Close
27.70
Year Change
-0.07
Year % Change
-0.07%
52 Week High
35.76
52 Week Low
25.92
Volume
3114911
Inc. Vol
561829

News - ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES

02-12:11 GMT
FC Barcelona Outcast Vitor Roque Will Ask To Be Sold If Club Forces Loan, Reports Mas Que Pelotas
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for SMCI
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for TSLA
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for NVDA
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for META
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for MSFT
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for AMZN
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for AAPL - Warren Buffett
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for AMD
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for GOOGL - Warren Buffett
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for AVGO
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for COIN
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for MU
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for MSTR
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for LLY
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:10 GMT
Guru Fundamental Report for TSM
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:08 GMT
Trump’s Plan To Deport 11 Million Undocumented Immigrants Impossible
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
The Full Potential Of The Voluntary Carbon Market Through Agriculture
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
‘Unfrosted’ Star Jim Gaffigan Talks Jerry Seinfeld, Pop-Tarts Movie’s Cast Of Comedy Greats
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
Taylor Swift Ties Drake For A Record No Musician Really Wants
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
Ryan Gosling’s ‘Fall Guy’ Flies High With Great Action, Laughs And Yes, Amazing Stunts
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
Powering The Next Generation Of Super Apps With Plotline
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
5 ChatGPT Prompts For A Winner’s Mindset (Make Success Inevitable)
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
Warren Buffett’s Top Jockeys: For The Kentucky Derby And Berkshire Hathaway
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-12:02 GMT
The Proactive Edge: Leveraging AI For Customer Retention Success
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:57 GMT
A 3D Printer On Every Desk? Why Companies Are Buying More 3D Printers
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
ONEOK a Top Socially Responsible Dividend Stock With 5.2% Yield (OKE)
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
OUTFRONT Media Reaches Analyst Target Price
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
PROCEPT BioRobotics Reaches Analyst Target Price
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
GRMN Crosses Above Average Analyst Target
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
Bet on Winning DuPont Analysis & Pick 5 Quality Stocks
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:53 GMT
AGCO's Strong Dividend History Helps Get It To The Top 25
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:49 GMT
‘Gray Zone Warfare’ Patch Notes Add Faction Change Option
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:47 GMT
Scalable Customer Success With AI
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:47 GMT
White Swan, Black Swan And QuantumBleed
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
AGCO's Strong Dividend History Helps Get It To The Top 25
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Regeneron Pharmaceuticals Q1 Profit Decreases, misses estimates
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ETF Fundamental Report for VYM
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ETF Fundamental Report for SCHD
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ETF Fundamental Report for VB
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ETF Fundamental Report for XLK
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ONEOK a Top Socially Responsible Dividend Stock With 5.2% Yield (OKE)
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
ETF Fundamental Report for VO
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
The Wendy's Company Q1 Profit Increases, beats estimates
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Lincoln National Corp. Q1 Earnings Summary
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Is Super Micro Computer Stock a Buy Right Now?
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
If You'd Invested $1,000 in Marvell Technology 5 Years Ago, Here's How Much You'd Have Today
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Baxter International Inc. Q1 Profit Decreases, but beats estimates
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Zoetis Inc. Q1 Profit Increases, beats estimates
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:44 GMT
Geron Corporation Q1 Loss increases, but beats estimates
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:34 GMT
Don’t Let AI Control Your Nukes, U.S. Official Urges China And Russia
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Common Expenses For Small-Business Owners That Are Not Deductible
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Kim Ki-Young’s Noir Film ‘An Experience To Die For’ To Screen In NYC
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Managing Digital Debt: Artificial Intelligence And Human Sustainability
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
America Requires Regulatory Clarity Before Blockchain Bears Its Bounty
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
ExxonMobil’s Transition Is Grounded In Facts About The New Energy Mix
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Advice For Tech Companies Looking To Establish Themselves In The UAE
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Adapting To The Future: The Role Of Digital Nomads In Shaping U.S. Market Dynamics
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:33 GMT
Almost 65,000 Job Cuts Were Announced In April—And AI Was Blamed For The Most Losses Ever
Source: Forbes World, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:27 GMT
DuPont de Nemours Reaches Analyst Target Price
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:27 GMT
CRS Crosses Above Average Analyst Target
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:27 GMT
Stocks Climb Before the Open After Fed Decision, Apple Earnings on Tap
Source: NASDAQ Stocks, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
How The Parts Add Up: XSVM Targets $61
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
The Implied Analyst 12-Month Target For VBK
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
How The Parts Add Up: DON Targets $51
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
5 Dividend Growth Stocks With Upside To Analyst Targets
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
What Will PayPal Stock Be Worth in 2025?
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
Where Will Lucid Motors Stock Be in 5 Years?
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
AMCR Crosses Above Average Analyst Target
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
02-11:19 GMT
Implied FVD Analyst Target Price: $45
Source: NASDAQ US Markets, Symbol: ROYALTY PHARMA PLC - CLASS A ORDINARY SHARES
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38103.96
134.59
0.35%
5056.63
28.28
0.56%
17488.55
115.81
0.67%
58916.00
475
0.81%
18007.00
41.62
0.23%
38236.41
387.69
1.02%
3104.82
-8.22
-0.26%
8167.99
45.22
0.56%
18221.12
625.21
3.55%
7596.52
35.75
0.47%
22648.20
43.35
0.19%
2299.72
-23.94
-1.03%
84.31
0.816
0.98%
1.06987
-0.00183
-0.17%
154.756
-0.97
-0.62%
1.25093
-0.00269
-0.21%
0.65302
0.00006
0.01%
1.37182
-0.00067
-0.05%
165.58400
-1.317
-0.79%
0.85528
0.00039
0.05%
193.59000
-1.63
-0.83%
0.91203
-0.00434
-0.47%
0.97576
-0.00633
-0.64%
0.59287
0.00001
0.00%
105.70700
0.076
0.07%
Top Gainers
Name
Last
+/-
%
5.13
3.50
214.72%
0.04
0.02
127.27%
3.27
1.81
123.97%
2.45
1.18
92.91%
0.49
0.21
72.78%
3.37
1.12
49.45%
0.06
0.02
46.30%
0.37
0.10
37.04%
0.96
0.25
35.08%
0.09
0.02
34.57%
Top Losers
Name
Last
+/-
%
0.31
-0.83
-73.20%
0.01
-0.02
-64.57%
0.00
-0.01
-58.42%
0.01
-0.01
-46.90%
0.13
-0.11
-46.19%
0.02
-0.02
-43.75%
0.10
-0.07
-40.85%
0.01
-0.01
-40.56%
0.07
-0.05
-39.25%
0.01
0.00
-39.20%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy